These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30431598)

  • 1. MLL-PTD in a 13-year-old patient with blast phase myeloproliferative neoplasm: A case report.
    He Z; Wang B; Chen L; Huang Y; Wang H; Yang M; Xiao X; Lu Y; Chen J; Wu Y
    Medicine (Baltimore); 2018 Nov; 97(46):e13220. PubMed ID: 30431598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Kong J; Gao MG; Qin YZ; Wang Y; Yan CH; Sun YQ; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
    BMC Cancer; 2022 Jan; 22(1):11. PubMed ID: 34979982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated Phase of Myeloproliferative Neoplasms.
    Shahin OA; Chifotides HT; Bose P; Masarova L; Verstovsek S
    Acta Haematol; 2021; 144(5):484-499. PubMed ID: 33882481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.
    Cherington C; Slack JL; Leis J; Adams RH; Reeder CB; Mikhael JR; Camoriano J; Noel P; Fauble V; Betcher J; Higgins MS; Gillette-Kent G; Tremblay LD; Peterson ME; Olsen JJ; Tibes R; Mesa RA
    Leuk Res; 2012 Sep; 36(9):1147-51. PubMed ID: 22578777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase].
    Yan X; Qin TJ; Li B; Qu SQ; Pan LJ; Li FH; Liu NN; Xiao ZJ; Xu ZF
    Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):276-283. PubMed ID: 37356995
    [No Abstract]   [Full Text] [Related]  

  • 6. Relapse kinetics in acute myeloid leukaemias with MLL translocations or partial tandem duplications within the MLL gene.
    Ommen HB; Hokland P; Haferlach T; Abildgaard L; Alpermann T; Haferlach C; Kern W; Schnittger S
    Br J Haematol; 2014 Jun; 165(5):618-28. PubMed ID: 24611505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The initial level of MLL-partial tandem duplication affects the clinical outcomes in patients with acute myeloid leukemia.
    Kong J; Zhao XS; Qin YZ; Zhu HH; Jia JS; Jiang Q; Wang J; Zhao T; Huang XJ; Jiang H
    Leuk Lymphoma; 2018 Apr; 59(4):967-972. PubMed ID: 28745571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
    Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C
    Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational landscape of blast phase myeloproliferative neoplasms (MPN-BP) and antecedent MPN.
    Pasca S; Chifotides HT; Verstovsek S; Bose P
    Int Rev Cell Mol Biol; 2022; 366():83-124. PubMed ID: 35153007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
    Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
    Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.
    Whitman SP; Ruppert AS; Marcucci G; Mrózek K; Paschka P; Langer C; Baldus CD; Wen J; Vukosavljevic T; Powell BL; Carroll AJ; Kolitz JE; Larson RA; Caligiuri MA; Bloomfield CD
    Blood; 2007 Jun; 109(12):5164-7. PubMed ID: 17341662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and predictors of survival in blast phase myeloproliferative neoplasms.
    Lancman G; Brunner A; Hoffman R; Mascarenhas J; Hobbs G
    Leuk Res; 2018 Jul; 70():49-55. PubMed ID: 29807273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias.
    Zorko NA; Bernot KM; Whitman SP; Siebenaler RF; Ahmed EH; Marcucci GG; Yanes DA; McConnell KK; Mao C; Kalu C; Zhang X; Jarjoura D; Dorrance AM; Heerema NA; Lee BH; Huang G; Marcucci G; Caligiuri MA
    Blood; 2012 Aug; 120(5):1130-6. PubMed ID: 22674806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease.
    Bernot KM; Nemer JS; Santhanam R; Liu S; Zorko NA; Whitman SP; Dickerson KE; Zhang M; Yang X; McConnell KK; Ahmed EH; Muñoz MR; Siebenaler RF; Marcucci GG; Mundy-Bosse BL; Brook DL; Garman S; Dorrance AM; Zhang X; Zhang J; Lee RJ; Blum W; Caligiuri MA; Marcucci G
    Blood; 2013 Nov; 122(23):3778-83. PubMed ID: 24085765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Application of Next-generation Sequencing Tumor Molecular Profiling in the Diagnosis and Management of a Case of Acute Myelogenous Leukemia With MLL-PTD in a Pediatric Heart Transplant Recipient.
    Woolbright WC; Wong V; Severson E; Kuo DJ
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e246-e249. PubMed ID: 32134843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia.
    Muto T; Takeuchi M; Yamazaki A; Sugita Y; Tsukamoto S; Sakai S; Takeda Y; Mimura N; Ohwada C; Sakaida E; Aotsuka N; Iseki T; Nakaseko C
    Int J Hematol; 2015 Jul; 102(1):86-92. PubMed ID: 25758097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD).
    Sun QY; Ding LW; Tan KT; Chien W; Mayakonda A; Lin DC; Loh XY; Xiao JF; Meggendorfer M; Alpermann T; Garg M; Lim SL; Madan V; Hattori N; Nagata Y; Miyano S; Yeoh AE; Hou HA; Jiang YY; Takao S; Liu LZ; Tan SZ; Lill M; Hayashi M; Kinoshita A; Kantarjian HM; Kornblau SM; Ogawa S; Haferlach T; Yang H; Koeffler HP
    Leukemia; 2017 Jan; 31(1):1-10. PubMed ID: 27389053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allo-SCT for  Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC).
    Cahu X; Chevallier P; Clavert A; Suarez F; Michallet M; Vincent L; Vigouroux S; Blaise D; Mariette C; Bilger K; Robin M; Yakoub-Agha I; Peffault de Latour R; Mohty M
    Bone Marrow Transplant; 2014 Jun; 49(6):756-60. PubMed ID: 24614840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms.
    Tam CS; Nussenzveig RM; Popat U; Bueso-Ramos CE; Thomas DA; Cortes JA; Champlin RE; Ciurea SE; Manshouri T; Pierce SM; Kantarjian HM; Verstovsek S
    Blood; 2008 Sep; 112(5):1628-37. PubMed ID: 18566326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a novel childhood acute myeloid leukaemia cell line, KOPM-88, containing partial tandem duplication of the MLL gene and an in vivo model for childhood acute myeloid leukaemia using NOD/SCID mice.
    Hayashi M; Kondoh K; Nakata Y; Kinoshita A; Mori T; Takahashi T; Sakamoto MI; Yamada T
    Br J Haematol; 2007 May; 137(3):221-32. PubMed ID: 17408461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.